If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page Weekly Newsletter
Click here to subscribe to our Magazine
World Forum For Medicine
Top Latest Press Releases
OTL -101 Has Received A Rare Paediadriatric Disease Announced By Orchard Therapeutics

TrialScope Launches New SaaS Clinical Trial Disclosure Management Tool: Core Disclosure

TrialScope, the global leader in clinical trial transparency and compliance solutions announced the launch of its newest solution, Core Disclosure. Promoting a new level of data efficiency accuracy and alignment.


Kite Doses First Patient in the Phase 2 Trial of Axicabtagene Ciloleucel in Indolent B-Cell Non-Hodgkin

Kite Pharma, Inc , a leading cell therapy company announced that patients with relapsed/refractory indolent B-cell non-Hodgkin lymphoma are now being treated in its Phase 2 ZUMA-5 tria...


FDA Issues Emergency Use Authorization for Thermo Fisher Scientific Zika Virus Assay

Thermo Fisher Scientific, the world leader in serving science announced that the U.S. FDA has issued an Emergency Use Authorization for the company new TaqPath Zika Virus Kit.

Cancer drug screening process saves discovery time and limits use of mice

Cancer drug screening process saves discovery time and limits use of mice

A method of testing drugs thatprompt the immune system to attack and destroy cancer cells has been developed which can speed up drug discovering andreducethe unnecessary use of mice in drug screening programmes..


TraceLink expands offering with ROC IT Solutions acquisition

TraceLink Inc., the world largest track and trace network for connecting the life sciences announced that it has acquired ROC IT Solutions, the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain.


Phase III study of viaskin peanut allergic of patients one to three years of age initiated by dbv tchnologies

DBV Technologiesannounced that the first patient has been enrolled in EPITOPE , a global, Phase III clinical trial assessing the safety and efficacy of...


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here


For the latest visit: www.worldpharmatoday.com

World Pharma Today